高雄市生物科技發展協會|http://www.khba.org.tw
會員登入
記住帳號 自動登入
會員名錄
各式辦法
下載專區
留言板
您目前的位置:首頁 / 活動與新訊
Neutrophils: Unraveling their multifaceted roles in inflammatory bowel disease and gut mic
活動日期:2024.03.14
2024.03.14  

Neutrophils: Unraveling their multifaceted roles in inflammatory bowel disease and gut microbiota 

https://www.news-medical.net/news/20231227/Neutrophils-Unraveling-their-multifaceted-roles-in-inflammatory-bowel-disease-and-gut-microbiota-interactions.aspx?azosrc=downloadpdfcopyemail

By Dec 27 2023Reviewed by Benedette Cuffari, M.Sc.

In a recent review published in the journal Nature Reviews Gastroenterology and Hepatology, researchers examine the multifaceted roles of neutrophils in inflammatory bowel disease (IBD) and highlight their interactions with the gut microbiota.

Study: Neutrophils: from IBD to the gut microbiota. Image Credit: BioFoto / Shutterstock.com Study: Neutrophils: from IBD to the gut microbiota. Image Credit: BioFoto / Shutterstock.com

Background 

IBD, which comprises Crohn's disease and ulcerative colitis, arises from genetic, microbial, and environmental factors. IBD often originates with loss-of-function mutations, which lead to reduced innate immune responses, suppression of microbiota control, secondary inflammation, and tissue damage.

Neutrophils, vital in innate immunity, are key in IBD, especially Crohn's disease; however, these inflammatory cells have been less studied than other immune cells like T-cells. Thus, further research is needed to fully understand the complex roles of neutrophils in IBD and their interactions with the gut microbiota.

Neutrophil diversity and plasticity

Contrary to previous beliefs that neutrophils are homogenous, recent studies have revealed their remarkable heterogeneity and adaptability in both health and disease. This complexity is especially apparent in IBD, where neutrophils have diverse phenotypes and functions. These discoveries challenge the traditional view of neutrophils as simple antimicrobial cells, thus highlighting their roles in modulating immune responses and interacting with the microbiota.

Recent advancements have led to the identification of several neutrophil subtypes, including low-density neutrophils (LDNs), normal-density neutrophils (NDNs), and tumor-associated neutrophils (TANs). However, the precise functional differences among these subtypes remain unclear. Additionally, neutrophils' distinct activation and maturation states and how they respond to local tissue environments add another layer to their complexity.

Dual roles of neutrophils in IBD

In IBD, neutrophils are crucial for intestinal barrier defense but also contribute to chronic inflammation and tissue damage. While essential for combating pathogens, the recruitment of neutrophils to the intestinal mucosa can lead to epithelial barrier disruption and exacerbate inflammation.

Genetics & Genomics - Second Edition eBook NEW EDITION NOW OUT - Compilation of the top interviews, articles, and news in the last year.Download the latest edition

Neutrophils amplify immune responses by releasing reactive oxygen species (ROS), cytotoxic granules, and neutrophil extracellular traps (NETs). These actions, while antimicrobial, can cause significant mucosal damage. Conversely, certain neutrophil subsets play a protective role in IBD by aiding in tissue repair and inflammation resolution.

The contribution of neutrophils to IBD varies among patients and is influenced by genetic predispositions and local environmental factors. Understanding these influences is key to developing targeted therapies that modulate neutrophil functions without compromising their essential roles.

Neutrophils, microbiota, and IBD

Over 350 IBD susceptibility genes are linked to neutrophil functions, thus emphasizing the importance of these cells in disease development, particularly at the host-microorganism interface. These genetic factors influence neutrophil behavior and microbiota composition, which underscores the complex dynamics of microbiota-neutrophil interactions in IBD.

Understanding the intricate relationship between neutrophils, the gut microbiota, and IBD is crucial for developing new therapeutic strategies. By targeting this interplay, it may be possible to address the unmet medical needs in IBD treatment by offering more effective and personalized approaches.

Neutrophils play a pivotal role in maintaining intestinal homeostasis by balancing the gut microbiota, encapsulating commensal microorganisms during inflammation, and controlling microbial populations. The recruitment of neutrophils to the intestinal mucosa, which relies on chemotaxis receptors like C-X-C motif chemokine receptor 2 (CXCR2) and cytokines like interleukin 17 (IL-17) is vital for this balance. Notably, neutrophils produce IL-22, thus reinforcing their role in bacterial containment and supporting epithelial restoration during colitis.

Chronic neutrophil infiltration during prolonged inflammation can significantly alter the intestinal environment. Their release of ROS creates a favorable milieu for pathobionts like Enterobacteriaceae species.

Neutrophils' granules release antimicrobial peptides (AMPs) that interact with the microbiota by altering local immunity and influencing microbiota composition. These mechanisms form part of the body's 'nutritional immunity,' in which neutrophils regulate the bioavailability of essential micronutrients to manipulate the growth of different bacterial species.

Regulation of neutrophil functions by microbiota

Under normal conditions, the microbiota exerts a significant influence on neutrophil functions, thus affecting their development, recruitment, activation, and maturation. This relationship becomes evident in inflammatory conditions like IBD, where direct interactions between microbiota and immune cells are intensified. 

The microbiota has a direct impact on neutrophil production in bone marrow. Factors derived from the microbiota, including ligands of toll-like receptors (TLRs) and nucleotide-binding oligomerization domain-containing proteins (NODs), travel from the gut to the bone marrow, thereby influencing myelopoiesis. This gut–bone marrow axis demonstrates the integral role of microbiota in regulating immune cell production.

The microbiota also influences neutrophil activation and maturation. In various experimental models, alterations in microbial diversity have been shown to impact neutrophil recruitment and response.

For example, neutrophils can selectively respond to different bacterial lipopolysaccharides (LPS), which affects their NETosis process. Additionally, probiotics like Lactobacillus rhamnosus strain GG have been found to inhibit neutrophil activation, thus demonstrating the potential of microbiota-derived factors to modulate neutrophil functions.

Short-chain fatty acids (SCFAs), such as propionate, acetate, and butyrate, play a significant role in influencing immune responses, including those of neutrophils. These metabolites impact neutrophil apoptosis, ROS production, and phagocytic activity. Other microbiota-derived metabolites, including bile acids and tryptophan catabolites, also modulate the intestinal environment, which indirectly affects neutrophil recruitment and activation.

Journal reference:

  • Danne, C., Skerniskyte, J., & Marteyn, B. (2023). Neutrophils: from IBD to the gut microbiota. Nature Reviews Gastroenterology & Hepatologydoi:10.1038/s41575-023-00871-3 

 

共有314筆資料 頁數: 第1頁(共16頁)
編號 標題 新增日期
1 《臍帶血》不如預期!!Gamida Cell異體造血幹細胞移植療法「Omi.. 2024.12.26
2 《臍帶血》儲存是醫療希望還是商業炒作?英國醫學期刊認為治療8.. 2024.12.26
3 《川普》請繫好安全帶!!川普”Make American Healthy Again”.. 2024.12.26
4 《FDA》加速審批(Accelerated Approval, AA)爭議延燒!美國FDA.. 2024.12.26
5 哈佛研究發現「甲狀腺素影響大腦活動」,神經退化性疾病治療有.. 2024.11.05
6 口腔「具核梭桿菌」竟和大腸癌有關!醫:刷牙不只是照顧口腔健康 2024.08.06
7 Breakthrough research unveils β-cell dynamics in Type 1 d.. 2024.08.05
8 New technique provides an unprecedented view inside the ce.. 2024.08.05
9 Study explores how different modes of cell division evolve.. 2024.08.05
10 升高再生高!!美國眾議院議長計劃今年投票通過使其成為法律 2024.08.05
11 預測未來2小時內的血糖濃度變化!!羅氏搭載AI的連續血糖監測系.. 2024.08.05
12 罔顧病患權益!!美國藥品福利管理公司(PBM)竟對患者獲取「負擔.. 2024.08.05
13 「不符商業目標」!必治妥施貴寶終止開發其多發性骨髓瘤雙特異.. 2024.08.05
14 Heavy Weightlifting Maintained Older People’s Long-Term S.. 2024.07.19
15 Fasting, Meal Substitute Improved Blood Sugar More Than Di.. 2024.07.19
16 每年至少有170萬成年人罹患!!FDA核准Prenosis軟體「ImmunoScor.. 2024.07.19
17 不向挫折低頭!禮來阿茲海默症藥物30年的研發艱辛路,終露曙光! 2024.07.19
18 Enzyme discovery paves the way for developing universal do.. 2024.06.05
19 曬太陽是最便宜最方便的減重方式?研究:紫外線可能影響皮下脂肪.. 2024.06.05
20 B cell trajectories influence cancer outcomes 2024.05.09
上一頁  1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16  下一頁
版權所有©2006 高雄市生物科技發展協會 所有文字、資料禁止轉用
地址:高雄市中正一路120號14樓之3 TEL:(07)591-9569 / FAX:(07)591-9018 / e-mail: khba.tw@gmail.com
累積進站人數:3123261